Prevalence and treatment patterns of physical impairments in patients with metastatic breast cancer

Andrea L Cheville, Andrea B. Troxel, Jeffrey R. Basford, Alice B. Kornblith

Research output: Contribution to journalArticle

104 Citations (Scopus)

Abstract

Purpose: Physical impairments cause profound functional declines in patients with cancer. Although common rehabilitation measures can address many impairments, the extent of their delivery is unknown. We studied these issues by quantifying physical impairments in patients with metastatic breast cancer and by assessing how they are addressed. Patients and Methods: A consecutive sample of 163 community-dwelling patients with metastatic breast cancer was stratified by Karnofsky performance score and administered the Medical Outcomes Study Physical Function Subscale and the Older Americans Resource Study Activities of Daily Living subscales. Cancer-related physical impairments were identified through a physical examination, the 6-Minute Walk Test, and the Functional Independence Measure Mobility Subscale. Patients were questioned regarding the nature, type, and setting of treatments for impairments. Physical rehabilitation needs were determined through a consensus process involving physiatrists and physical/ occupational therapists specializing in cancer. Results: Ninety-two percent of patients (150 of 163) had at least one physical impairment. Among 530 identified impairments, 484 (92%) required a physical rehabilitation intervention and 469 (88%) required physical therapy (PT) and/or occupational therapy (OT). Only 30% of impairments requiring rehabilitation services and 21% of those requiring PT/OT received treatment. Impairments detected during hospitalization were overwhelmingly more likely to receive a rehabilitation intervention (odds ratio [OR] = 87.9; 95% CI, 28.5 to 271.4), and PT/OT (OR = 558.8; 95% CI, 187.0 to 1,669.6). Low socioeconomic and minority status were significantly associated with nontreatment. Conclusion: Remediable physical impairments were prevalent and poorly addressed among patients with metastatic breast cancer, drastically so in the outpatient setting. Undertreatment was particularly prominent among minority and socioeconomically disadvantaged groups.

Original languageEnglish (US)
Pages (from-to)2621-2629
Number of pages9
JournalJournal of Clinical Oncology
Volume26
Issue number16
DOIs
StatePublished - 2008
Externally publishedYes

Fingerprint

Breast Neoplasms
Rehabilitation
Occupational Therapy
Therapeutics
Odds Ratio
Independent Living
Neoplasms
Physical Therapists
Vulnerable Populations
Activities of Daily Living
Social Class
Physical Examination
Hospitalization
Outpatients
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Prevalence and treatment patterns of physical impairments in patients with metastatic breast cancer. / Cheville, Andrea L; Troxel, Andrea B.; Basford, Jeffrey R.; Kornblith, Alice B.

In: Journal of Clinical Oncology, Vol. 26, No. 16, 2008, p. 2621-2629.

Research output: Contribution to journalArticle

Cheville, Andrea L ; Troxel, Andrea B. ; Basford, Jeffrey R. ; Kornblith, Alice B. / Prevalence and treatment patterns of physical impairments in patients with metastatic breast cancer. In: Journal of Clinical Oncology. 2008 ; Vol. 26, No. 16. pp. 2621-2629.
@article{26fbe4f348024460a43c164f1aa8a43a,
title = "Prevalence and treatment patterns of physical impairments in patients with metastatic breast cancer",
abstract = "Purpose: Physical impairments cause profound functional declines in patients with cancer. Although common rehabilitation measures can address many impairments, the extent of their delivery is unknown. We studied these issues by quantifying physical impairments in patients with metastatic breast cancer and by assessing how they are addressed. Patients and Methods: A consecutive sample of 163 community-dwelling patients with metastatic breast cancer was stratified by Karnofsky performance score and administered the Medical Outcomes Study Physical Function Subscale and the Older Americans Resource Study Activities of Daily Living subscales. Cancer-related physical impairments were identified through a physical examination, the 6-Minute Walk Test, and the Functional Independence Measure Mobility Subscale. Patients were questioned regarding the nature, type, and setting of treatments for impairments. Physical rehabilitation needs were determined through a consensus process involving physiatrists and physical/ occupational therapists specializing in cancer. Results: Ninety-two percent of patients (150 of 163) had at least one physical impairment. Among 530 identified impairments, 484 (92{\%}) required a physical rehabilitation intervention and 469 (88{\%}) required physical therapy (PT) and/or occupational therapy (OT). Only 30{\%} of impairments requiring rehabilitation services and 21{\%} of those requiring PT/OT received treatment. Impairments detected during hospitalization were overwhelmingly more likely to receive a rehabilitation intervention (odds ratio [OR] = 87.9; 95{\%} CI, 28.5 to 271.4), and PT/OT (OR = 558.8; 95{\%} CI, 187.0 to 1,669.6). Low socioeconomic and minority status were significantly associated with nontreatment. Conclusion: Remediable physical impairments were prevalent and poorly addressed among patients with metastatic breast cancer, drastically so in the outpatient setting. Undertreatment was particularly prominent among minority and socioeconomically disadvantaged groups.",
author = "Cheville, {Andrea L} and Troxel, {Andrea B.} and Basford, {Jeffrey R.} and Kornblith, {Alice B.}",
year = "2008",
doi = "10.1200/JCO.2007.12.3075",
language = "English (US)",
volume = "26",
pages = "2621--2629",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "16",

}

TY - JOUR

T1 - Prevalence and treatment patterns of physical impairments in patients with metastatic breast cancer

AU - Cheville, Andrea L

AU - Troxel, Andrea B.

AU - Basford, Jeffrey R.

AU - Kornblith, Alice B.

PY - 2008

Y1 - 2008

N2 - Purpose: Physical impairments cause profound functional declines in patients with cancer. Although common rehabilitation measures can address many impairments, the extent of their delivery is unknown. We studied these issues by quantifying physical impairments in patients with metastatic breast cancer and by assessing how they are addressed. Patients and Methods: A consecutive sample of 163 community-dwelling patients with metastatic breast cancer was stratified by Karnofsky performance score and administered the Medical Outcomes Study Physical Function Subscale and the Older Americans Resource Study Activities of Daily Living subscales. Cancer-related physical impairments were identified through a physical examination, the 6-Minute Walk Test, and the Functional Independence Measure Mobility Subscale. Patients were questioned regarding the nature, type, and setting of treatments for impairments. Physical rehabilitation needs were determined through a consensus process involving physiatrists and physical/ occupational therapists specializing in cancer. Results: Ninety-two percent of patients (150 of 163) had at least one physical impairment. Among 530 identified impairments, 484 (92%) required a physical rehabilitation intervention and 469 (88%) required physical therapy (PT) and/or occupational therapy (OT). Only 30% of impairments requiring rehabilitation services and 21% of those requiring PT/OT received treatment. Impairments detected during hospitalization were overwhelmingly more likely to receive a rehabilitation intervention (odds ratio [OR] = 87.9; 95% CI, 28.5 to 271.4), and PT/OT (OR = 558.8; 95% CI, 187.0 to 1,669.6). Low socioeconomic and minority status were significantly associated with nontreatment. Conclusion: Remediable physical impairments were prevalent and poorly addressed among patients with metastatic breast cancer, drastically so in the outpatient setting. Undertreatment was particularly prominent among minority and socioeconomically disadvantaged groups.

AB - Purpose: Physical impairments cause profound functional declines in patients with cancer. Although common rehabilitation measures can address many impairments, the extent of their delivery is unknown. We studied these issues by quantifying physical impairments in patients with metastatic breast cancer and by assessing how they are addressed. Patients and Methods: A consecutive sample of 163 community-dwelling patients with metastatic breast cancer was stratified by Karnofsky performance score and administered the Medical Outcomes Study Physical Function Subscale and the Older Americans Resource Study Activities of Daily Living subscales. Cancer-related physical impairments were identified through a physical examination, the 6-Minute Walk Test, and the Functional Independence Measure Mobility Subscale. Patients were questioned regarding the nature, type, and setting of treatments for impairments. Physical rehabilitation needs were determined through a consensus process involving physiatrists and physical/ occupational therapists specializing in cancer. Results: Ninety-two percent of patients (150 of 163) had at least one physical impairment. Among 530 identified impairments, 484 (92%) required a physical rehabilitation intervention and 469 (88%) required physical therapy (PT) and/or occupational therapy (OT). Only 30% of impairments requiring rehabilitation services and 21% of those requiring PT/OT received treatment. Impairments detected during hospitalization were overwhelmingly more likely to receive a rehabilitation intervention (odds ratio [OR] = 87.9; 95% CI, 28.5 to 271.4), and PT/OT (OR = 558.8; 95% CI, 187.0 to 1,669.6). Low socioeconomic and minority status were significantly associated with nontreatment. Conclusion: Remediable physical impairments were prevalent and poorly addressed among patients with metastatic breast cancer, drastically so in the outpatient setting. Undertreatment was particularly prominent among minority and socioeconomically disadvantaged groups.

UR - http://www.scopus.com/inward/record.url?scp=45749142154&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45749142154&partnerID=8YFLogxK

U2 - 10.1200/JCO.2007.12.3075

DO - 10.1200/JCO.2007.12.3075

M3 - Article

C2 - 18509174

AN - SCOPUS:45749142154

VL - 26

SP - 2621

EP - 2629

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 16

ER -